Latest Ratios: P/E Ratio 5.9x · EV/EBITDA 5.5x · ROE 5.8%. (2017–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $392M | $148M | $464M | — | — | — | — | — | — | — |
| Enterprise Value | $1.4B | $3.5B | $4.0B | — | — | — | — | — | — | — |
| P/E Ratio → | 5.90 | 1.61 | 4.21 | — | — | — | — | — | — | — |
| P/S Ratio | 0.30 | 0.03 | 0.11 | — | — | — | — | — | — | — |
| P/B Ratio | 0.31 | 0.08 | 0.29 | — | — | — | — | — | — | — |
| P/FCF | 8.27 | 0.92 | 0.80 | — | — | — | — | — | — | — |
| P/OCF | 5.51 | 0.61 | 0.69 | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.79 | 0.91 | — | — | — | — | — | — | — |
| EV / EBITDA | 5.46 | 4.06 | 4.14 | — | — | — | — | — | — | — |
| EV / EBIT | 7.38 | 5.47 | 5.98 | — | — | — | — | — | — | — |
| EV / FCF | — | 21.44 | 6.92 | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 37.9% | 37.9% | 39.3% | 37.0% | 35.9% | 35.7% | 36.7% | 38.9% | 42.2% | 41.6% |
| Operating Margin | 14.4% | 14.4% | 17.0% | 14.1% | 9.9% | 6.7% | 8.2% | 12.1% | 10.5% | 8.2% |
| Net Profit Margin | 2.2% | 2.2% | 2.5% | -6.6% | -3.5% | -1.4% | -0.5% | 5.3% | 4.2% | 3.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 5.8% | 5.8% | 6.5% | -15.2% | -8.1% | -4.4% | -1.2% | 13.1% | 9.2% | 8.7% |
| ROA | 1.4% | 1.4% | 1.5% | -3.6% | -1.8% | -1.0% | -0.3% | 4.0% | 3.0% | 3.2% |
| ROIC | 9.2% | 9.2% | 10.5% | 7.9% | 5.4% | 5.4% | 5.8% | 9.8% | 8.3% | 9.5% |
| ROCE | 11.7% | 11.7% | 13.4% | 11.2% | 8.3% | 6.1% | 7.0% | 13.0% | 10.6% | 13.3% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 2.07 | 2.07 | 2.32 | 2.21 | 2.25 | 2.73 | 2.08 | 1.47 | 1.40 | 0.97 |
| Debt / EBITDA | 4.28 | 4.28 | 3.90 | 5.02 | 9.21 | 7.27 | 7.40 | 3.79 | 6.09 | 2.75 |
| Net Debt / Equity | — | 1.88 | 2.18 | 2.07 | 2.12 | 2.48 | 1.55 | 1.40 | 1.19 | 0.84 |
| Net Debt / EBITDA | 3.89 | 3.89 | 3.66 | 4.71 | 8.66 | 6.59 | 5.52 | 3.63 | 5.18 | 2.38 |
| Debt / FCF | — | 20.53 | 6.11 | 8.82 | 309.49 | — | 36.94 | 16.98 | 9.06 | 2.34 |
| Interest Coverage | 1.46 | 1.46 | 1.38 | 0.77 | 0.77 | 0.97 | 0.68 | 3.08 | 3.53 | 2.53 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.11 | 1.11 | 0.88 | 0.92 | 0.42 | 0.96 | 1.48 | 0.75 | 0.94 | 0.61 |
| Quick Ratio | 1.01 | 1.01 | 0.80 | 0.84 | 0.39 | 0.87 | 1.38 | 0.69 | 0.87 | 0.54 |
| Cash Ratio | 0.22 | 0.22 | 0.17 | 0.20 | 0.07 | 0.20 | 0.61 | 0.06 | 0.23 | 0.13 |
| Asset Turnover | — | 0.60 | 0.62 | 0.50 | 0.37 | 0.68 | 0.54 | 0.73 | 0.49 | 1.04 |
| Inventory Turnover | 16.52 | 16.52 | 18.51 | 18.70 | 17.95 | 20.23 | 17.39 | 22.79 | 15.64 | 23.57 |
| Days Sales Outstanding | — | 87.85 | 80.05 | 81.07 | 85.48 | 66.91 | 93.70 | 75.40 | 100.92 | 35.34 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | 0.2% | — | — | — | — | — | — | — |
| Payout Ratio | — | — | 1.0% | — | — | — | — | 13.8% | 27.6% | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 16.9% | 62.2% | 23.8% | — | — | — | — | — | — | — |
| FCF Yield | 12.1% | 109.2% | 124.5% | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | — | — | — | — | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.2% | — | — | — | — | — | — | — |
| Shares Outstanding | — | $30M | $68M | $44M | $45M | $48M | $45M | $43M | $37M | $37M |
Currency and integration volatility
Based on current market data, Auna trades at a P/S of 0.30 and a forward P/E of 1.70, suggesting that investors are heavily discounting the company's valuation due to the significant execution risks inherent in its recent cross-border expansion and the volatility of its regional earnings profile.
The extremely low forward P/E multiple implies that the market is skeptical of the company's ability to convert its massive revenue base into sustainable, high-quality earnings. This valuation gap compared to regional peers suggests that the market is pricing in a high probability of further margin compression or capital structure adjustments.
As reported in financial statements, Auna's ROIC has remained stagnant, hovering near 2.2% in 2026Q1, which indicates that the company is struggling to generate meaningful returns on its invested capital despite its aggressive strategy of scaling through large-scale clinical acquisitions across Latin America.
The persistent low ROIC suggests that the capital deployed for the OCA acquisition and other regional assets has yet to reach an inflection point of synergy realization. Investors should monitor whether management can improve asset utilization, as current returns remain well below the cost of capital typically associated with high-acuity healthcare infrastructure.
According to recent quarterly filings, Auna's cash conversion cycle remains volatile, shifting from -13 days in 2024Q1 to -27 days in 2026Q1, reflecting the complex interplay between its insurance-like prepaid plan collections and the high-overhead, transactional nature of its hospital service operations.
The negative cash conversion cycle is a structural feature of the prepaid plan model, where cash is collected upfront, yet the variability in DSO and DPO suggests inconsistent management of supplier relationships and patient receivables. This inconsistency warrants further investigation into whether the company is relying on extended payables to mask underlying liquidity pressures.
Based on reported figures, Auna's debt-to-equity ratio of 1.99 as of 2026Q1 highlights a reliance on leverage that, when combined with an interest coverage ratio of 1.14, suggests the company has limited room for error in its debt service obligations during periods of regional economic volatility.
The high debt-to-EBITDA ratio of 17.98 indicates that the company's current earnings power is insufficient to deleverage the balance sheet rapidly. This leverage profile appears to be a significant overhang, potentially restricting management's ability to pursue further growth initiatives without additional equity dilution or refinancing at unfavorable rates.
Investors frequently misapply standard EV/EBITDA multiples to Auna, failing to account for the unique, high-margin data-rich ecosystem of its prepaid plan segment, which is fundamentally different from the asset-heavy, low-margin clinical delivery models of traditional hospital operators like HCA or Tenet Healthcare.
By treating Auna as a pure-play hospital operator, analysts overlook the potential for operating leverage inherent in the integrated payor-provider model. A more appropriate metric would be an adjusted EBITDA that accounts for the deferred revenue recognition in the insurance segment, which currently obscures the true underlying profitability of the business.
Includes 30+ ratios · 9 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying AUNA stock.
Auna S.A.'s current P/E ratio is 5.9x. The historical average is 2.9x. This places it at the 100th percentile of its historical range.
Auna S.A.'s current EV/EBITDA is 5.5x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 4.1x.
Auna S.A.'s return on equity (ROE) is 5.8%. The historical average is 1.6%.
Based on historical data, Auna S.A. is trading at a P/E of 5.9x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Auna S.A. has 37.9% gross margin and 14.4% operating margin. Operating margin between 10-20% is typical for established companies.
Auna S.A.'s Debt/EBITDA ratio is 4.3x, indicating high leverage. A ratio above 4x may signal elevated financial risk.